1.
Yoshino H, Imi T, Nukii Y, Hosokawa K, Yamada S, Nakagawa S, Higashi D, Sakai S, Fujii S, Hiratsuka A, Hatada T, Yoroidaka T, Mizumaki H, Zaimoku Y, Yoshida A, Maruyama H, Watanabe S, Ueda T, Ito Y, Horie M, Toho M, Matsue K, Takamatsu H, Miyamoto T. Parkinsonism-like delayed neurotoxicity after idecabtagene vicleucel therapy for multiple myeloma: clinicopathological, cerebrospinal fluid, and autopsy analyses. Haematologica; https://doi.org/10.3324/haematol.2026.300852 [Early view].